Literature DB >> 22795737

Ablation of typical right atrial flutter in patients with pulmonary hypertension.

Ulrich Luesebrink1, Dieter Fischer, Funda Gezgin, David Duncker, Thorben Koenig, Hanno Oswald, Gunnar Klein, Ajmal Gardiwal.   

Abstract

BACKGROUND: RF ablation for cavotricuspid isthmus (CTI) dependent flutter is an established therapy. Right atrial hypertrophy and enlargement are associated with the occurrence of cavotricuspid isthmus dependent flutter. Therefore, patients with pulmonary hypertension (PAH) are prone to atrial arrhythmias like cavotricuspid isthmus dependent flutter. However, the influence of PAH on typical atrial flutter ablation procedure has not been systematically examined.
METHODS: In a retrospective single-centre analysis data of patients undergoing an ablation procedure for cavotricuspid isthmus dependent flutter between January 2007 and October 2009 at Hannover Medical School, Germany were analysed. Only procedures performed by experienced electrophysiologists with an 8mm RF-ablation catheter were included. Data for 196 patients were analysed. Thirty-eight patients were identified with PAH and were compared to 158 patients without PAH for procedural ablation parameters, procedure time, ablation time, ablation points and fluoroscopy time.
RESULTS: A bidirectional block of the CTI was achieved in all patients. Patients with severe PAH had a significantly longer procedure time (78±40 min vs. 62±29 min; p=0.033), total ablation time (20±11 min vs. 15±9 min; p=0.02) and more ablation lesions (26±16 vs. 19±12; p=0.018) as compared to patients without PAH.
CONCLUSION: Cavotricuspid isthmus dependent flutter ablation in patients with PAH is associated with longer procedure duration and a greater amount of cumulative tissue ablation needed to achieve bidirectional block of the CTI compared to patients without pulmonary hypertension.
Copyright © 2012 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22795737     DOI: 10.1016/j.hlc.2012.06.005

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  9 in total

Review 1.  [Arrhythmias in patients with pulmonary hypertension and chronic lung disease].

Authors:  Dirk Bandorski; Reinhard Höltgen; Ardeschir Ghofrani; Viktoria Johnson; Jörn Schmitt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2019-08-22

2.  [Pulmonary hypertension: Possible genetic causes and therapeutic options].

Authors:  E Grünig; C A Eichstaedt; N Ehlken; E Mayer; H Klose
Journal:  Herz       Date:  2015-05       Impact factor: 1.443

Review 3.  Management of arrhythmias in pulmonary hypertension.

Authors:  S Ashwin Reddy; Sarah L Nethercott; Bharat V Khialani; Andrew A Grace; Claire A Martin
Journal:  J Interv Card Electrophysiol       Date:  2021-04-05       Impact factor: 1.900

Review 4.  Regulation and interactions in the activation of cell-associated plasminogen.

Authors:  H Myöhänen; A Vaheri
Journal:  Cell Mol Life Sci       Date:  2004-11       Impact factor: 9.261

5.  Atrial Arrhythmias in Pulmonary Hypertension: Pathogenesis, Prognosis and Management.

Authors:  Brett Wanamaker; Thomas Cascino; Vallerie McLaughlin; Hakan Oral; Rakesh Latchamsetty; Konstantinos C Siontis
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-03

6.  Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact.

Authors:  Valentina Mercurio; Grace Peloquin; Khalil I Bourji; Nermin Diab; Takahiro Sato; Blessing Enobun; Traci Housten-Harris; Rachel Damico; Todd M Kolb; Stephen C Mathai; Ryan J Tedford; Carlo G Tocchetti; Paul M Hassoun
Journal:  Pulm Circ       Date:  2018-03-26       Impact factor: 3.017

7.  Left atrial ablation for the management of atrial tachyarrhythmias in patients with pulmonary hypertension: A case series.

Authors:  Thomas A Boyle; Usama A Daimee; Catherine E Simpson; Todd M Kolb; Stephen C Mathai; Tauseef Akhtar; Daniel Nyhan; Hugh Calkins; David Spragg
Journal:  HeartRhythm Case Rep       Date:  2022-01-27

8.  Electrophysiological studies in patients with pulmonary hypertension: a retrospective investigation.

Authors:  Dirk Bandorski; Jörn Schmitt; Claudia Kurzlechner; Damir Erkapic; Christian W Hamm; Werner Seeger; Ardeschir Ghofrani; Reinhard Höltgen; Henning Gall
Journal:  Biomed Res Int       Date:  2014-05-26       Impact factor: 3.411

9.  Radiofrequency Catheter Ablation of Supraventricular Tachycardia in Patients With Pulmonary Hypertension: Feasibility and Long-Term Outcome.

Authors:  Bin Zhou; Yong-Jian Zhu; Zheng-Qin Zhai; Si-Xian Weng; Ya-Zhe Ma; Feng-Yuan Yu; Ying-Jie Qi; Yi-Zhou Jiang; Xin Gao; Xi-Qi Xu; Xin Jiang; Zhi-Cheng Jing; Min Tang
Journal:  Front Physiol       Date:  2021-06-18       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.